SMERUD MEDICAL RESEARCH INTERNATIONAL AS
Home | SMERUD MEDICAL RESEARCH INTERNATIONAL AS
SMERUD, a leading CRO, offers full-service clinical solutions to biotech, pharma, med-tech & academic sponsors.
Links
Organization
- CEO
- KT
- Chairman of the board
- KT
- Years since formation
- 30 years
- since Feb 20, 1995
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 12
Ownership
- Number of shares and share classes
- 1,100
- 1 share class
- Total number of shareholders
- 1
- company
- Belongs to group of
Financials
- Total operating income 2024
- 108,307,634
- NOK
- Annual total result 2024
- 8,964,355
- NOK
- Total equity 2024
- 26,451,084
- NOK
Last update: Sep 9, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
KT | Managing Director/CEO | 100 % indirectly |
Board
| Name | Role | Shares |
|---|---|---|
KT | Chairman | 100 % indirectly |
HK | Alternate Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - | |
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
KT | Managing Director/CEO, Chairman | 100 % indirectly |
Last update: Sep 17, 2024
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 1,100 | 100 % |
Shares owned by the SMERUD MEDICAL RESEARCH INTERNATIONAL AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| NO0010813736 | 1,275,760 | 2.8 % | |
| NO0012753625 | 1,219,512 | 1.71 % | |
| Ordinary shares | 60,000 | 1.58 % | |
| Ordinary shares | 2,551,520 | 0.46 % | |
| NO0010549801 | 26,467 | 0.14 % | |
| NO0010000045 | 350 | < 0.01 % | |
| NO0010405640 | 35 | < 0.01 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2024: NOK 0Operating profit 2024: NOK -95,650Employees: 0
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 108,307,634 | 95,339,773 | 63,455,965 | 37,973,563 |
Annual Total Result | 8,964,355 | 15,338,136 | 5,811,649 | 2,191,854 |
Total assets | 47,612,363 | 40,165,876 | 47,466,976 | 28,828,211 |
Total liabilities | 21,161,279 | 22,305,559 | 34,648,742 | 21,821,626 |
Total equity | 26,451,084 | 17,860,316 | 12,818,234 | 7,006,584 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 108,307,634 | 95,339,773 | 63,455,965 | 37,973,563 |
Total operating costs | 97,539,202 | 74,668,276 | 56,430,438 | 35,301,539 |
Operating result | 10,768,433 | 20,671,497 | 7,025,527 | 2,672,024 |
Financial income/costs | -376,619 | -512,370 | -1,213,877 | -480,169 |
Profit before tax | 10,391,814 | 20,159,128 | 5,811,649 | 2,191,854 |
Total tax & extraordinary income/cost | 1,427,459 | 4,820,992 | 0 | 0 |
Annual Total Result | 8,964,355 | 15,338,136 | 5,811,649 | 2,191,854 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 4,133,750 | 4,290,897 | 4,431,288 | 450,817 |
Total current assets | 43,478,613 | 35,874,979 | 43,035,688 | 28,377,394 |
Total assets | 47,612,363 | 40,165,876 | 47,466,976 | 28,828,211 |
Short term debt | 21,161,279 | 22,305,559 | 34,648,742 | 21,821,626 |
Long term debt | 0 | 0 | 0 | 0 |
Total liabilities | 21,161,279 | 22,305,559 | 34,648,742 | 21,821,626 |
Contributed capital | 5,672,547 | 5,672,547 | 5,672,547 | 5,672,547 |
Retained earnings | 20,778,537 | 12,187,769 | 7,145,687 | 1,334,037 |
Total equity | 26,451,084 | 17,860,316 | 12,818,234 | 7,006,584 |
Total equity and liabilities | 47,612,363 | 40,165,876 | 47,466,976 | 28,828,211 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises